Unit 3 Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Hormones

A

Chemicals that send signals to different parts of the body, either to or from the body to or from the brain. Required to produce Gender.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Steroid Hormone

A

Body -> Brain. Hydrophobic, thus bypasses the hydrophobic blood-brain barrier. In utero: causes physical differences btw genders (genitalia/musculoskeletal). Puberty: activates expression of sexual physiology and gamete formation. All steroid based on cholesterol.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Peptide Hormone

A

Brain -> Body. Hydrophilic. Not restricted by blood brain barrier. Produced by proteolysis from precursor proteins. IE vasopressin, oxytocin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Proteolysis

A

Process by which peptides are produced by being broken off from larger “precursor” proteins. Can lead to multiples effects and reactions to stress (ACTH [stress] is cleaved off of POMC precursor, but so is enkephalin [pain relief]).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Anterior Pituitary

A

Contains endocrine cells controlled by cells in the hypothalamus. Hypothalamus cells release neurotransmitters into the blood to start up endocrine cells in AP (pituicytes) to release hormones into brain. Contains larger variety of cells and peptides than posterior.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Posterior Pituitary

A

Contains pre-synaptic terminals from cells in the hypothalamus. Offers a direct connection between the brain and body as peptides are directly released into the blood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pituitary Gland

A

Master gland. Controls release of peptide hormones into the bloodstream. Essentially is a portal system through which the brain interacts with the body chemically.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hypothalamus

A

Site of synthesis of peptide hormones. Releases hormones into blood via terminals in the posterior pituitary.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Vasopressin

A

ADH (anti-diurectic hormone). Controls water retention. Stops bed-wetting. Influence sex behavior in males and maternal behavior in females.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Oxytocin

A

Controls uterine contractions during labor and milk letdown from breasts. Influence sex behavior in males and maternal behavior in females.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Corticotrophs

A

A pituicyte in the ant. pituitary. Synthesizes POMC (precursor protein), and thus secretes ACTH (stress) into the blood stream. Hormone release from the AP is stimulated by Thyrotropin (Corticotropin Releasing Thyroid Hormone) producing cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Gonadotrophs

A

A pituicyte in the ant. pituitary. Synthesizes and secretes Follical Stimulating Hormone (FSH) and Lutenizing Hormone (LH) into blood supply. Release from AP is stimulated by Gonadotropin Releasing Hormone (GnRH) cells in the hypthalamus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Negative Feedback in the Pituitary Gland

A

Body must maintain homeostasis, thus some hormones have actions that prevent further production of the hormone. EG: HPA Axis: Hypothalamus releases CRH -> AP releasing ACTH -> Adrenal Cortex releasing cortisol -> cortisol inhibits CRH and ACTH release.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Genomic vs. Non-Genomic Effects of Steroid Hormone

A

Genomic: Passes through membrane onto a nuclear receptor on the nucleus where it activates the relevant genes (SLOW).
Non-Genomic: Lands on a membrane receptor which activates 2nd messengers (FAST).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Progesterone/Estradiol

A

Steroid Hormones responsible for female reproduction. High concentration in breasts, vagina, uterus, and assoc brain regions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Testosterone

A

Steroid hormone with organization and activational role in male reproduction. High concentration in male genitalia, hair follices, muscle groups, and assoc. brain regions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Cortisol

A

Steroid hormone related to stress in males and females.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Steroid Conversion

A

Aromatase turns testosterone carbon ring into estrogen by aromatization. Causes gynoclymastia
Reductase turns testosterone carbon into ditestosterone by adding a Carbon ring. Causes male baldness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Steroids and Gender

A

Men and women both have testosterone and estrogen (among others), just in different levels. Steroid responsiveness is determine by presence and concentration of receptor, not hormone.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Primary Sexual Characteristics

A

Determined by genotype in the developmental state of the primordial gonad. Y chromosome: gene for the testosterone-sensitive Testes Determination Factor, which signals formation of testes instead of ovaries. If no testosterone, no testes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Secondary Sexual Characteristics

A

More visible expressions of gender. Determined by the presence or absence of estrogen/testosterone activity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Castration

A

Produces a feminizing effect before puberty.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Testicular Feminization Syndrome

A

XY genotype but unresponsive to androgen, thus develops as the default female phenotype.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Homosexuality

A

No natural equivalent for exclusive homosexuality in animal kingdom, and no evolutionary pressures for non-reproductive behaviors. Early theory by LeVay: smaller hypothalamus. Debunked b/c subjects were HIV+.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Testosterone Levels

A

Rises rapidly after puberty, peaks around mid-20s, and slowly declines thereafter, dropping after 60. Link between blood testosterone, aging, and sex activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Female Receptivity

A

Passive females accepts male sexual activity. Early theory of all sexuality.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Female Selectivity

A

Females are discriminate, only accepting advances from dominant males.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Female Proceptivity

A

Females are aggressive and actively seek sexual contact. Driven behavior: Alpha has sex -> overthrown by others -> new alpha having sex = Genetic Variability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Female Menstrual Cycle

A

CONSULT DIAGRAMS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Estrus Sex Behavior

A

Sex only at certain times, usually peri-ovulatory. Males very interested at only this time, otherwise are hunting/foraging/etc. Largely in animals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Menstrual Sex Behavior

A

Sexual behavior throughout cycle with increased frequency and constant male attendance necessary. Leads to tribal groups as females cannot be left alone. Human behavior

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Lutenizing-hormone Releasing Hormone

A

Produces sexual behavior in female mammals.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Fixed Action Patterns

A

Discrete stages of mating.
Ultimate Fixed Action Patterns: responsible for initiating causal event (attraction, arousal) [Lordosis: female arching of spine].
Proximate Fixed Action Patterns: direct cause and effect (copulation) [erection, intromission, ejaculation in males]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

SEXY BRAIN STUFF

A

CONSULT OTHERS’ NOTES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Pharmacology

A

Study of the action of drugs on living organisms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Neuropharmacology

A

Drug-induced changes in functioning of nerve cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Psychopharmacology

A

Drug-induced changes in behavior

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Neuropsychopharmacology

A

Drug-induced changes in the function of select neurons that influence specific behaviors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Drug Action

A

Molecular changes produced by drug binding to target site or receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Drug Effects

A

Molecular changes that alter physiological/psychological function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Therapeutic Drug Effects

A

Drug/receptor interactions that produce the desired effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Drug Side Effects

A

All non-desired drug effects varying from annoying to dangerous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Depressants

A

Produce general decrease in cognitive and behavior processes. Ex: marijuana, barbituates, benzos

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Stimulants

A

Produce general increase in behavior and thought. Ex: nicotine, caffeine, amphetamines, cocaine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Hallucinogens/Opiates

A

Alter perception of reality. Ex: LSD, opium

46
Q

Pharmacokinetic Factors Determining Drug Action

A

Discrete Factors: 1) route of administration 2) absorption/distribution 3) Binding characteristics 4) Inactivation 5) Elimination. Influenced by chemical structure of the drug (how it interacts w/ body), dosage, and bioavailability (amount of drug in blood available to bind to target)

47
Q

Drug Administration

A

Determines how quickly and how much is liberated and absorbed into the blood and how quickly it reaches its target and induces drug effect.

48
Q

Liberation

A

Release of a drug into a biological system from an administered form. Drugs are mixed with excipients that allow drug to exist in different forms. Also different formulations: time or sustained release.

49
Q

Time vs. Sustained Release

A

Time release: drug released slowly -> longer active time, more need to be taken to keep peak.
Sustained release: drug released in layers -> more peaks in less time.

50
Q

Oral Administration (PO)

A

Most common and convenient. Is difficult route as the drug must survive the harsh stomach environment and reach blood capillaries which makes it an inefficient method. Also, majority of PO drugs not fully absorbed until they reach small intestine. Absorption influenced by: food in stomach (large amounts/fatty foods slow drug movement, absorption), and First Pass Effect (absorbed PO drugs go straight to liver which lowers bioavailability of drug -> slow, unpredictable levels)

51
Q

Intravenous Administration (IV)

A

Directly into blood stream. Most common in medicine as it is an effective, easy, and rapid route as it circumvents stomach and first pass effect. Complication with high doses. Quick onset = immediate brain effect = little room for correction. Requires sterile environment. Dissolving of drugs in fillers may pose hazard.

52
Q

Subcutaneous Administration (SC)

A

Beneath the skin. Easy route w/ slow and prolonged absorption, though is subject to variable absorption depending on blood flow

53
Q

Intramuscular Administration (IM)

A

Into muscle tissue. Easy route w/ slow and even absorption. Often localized irritation at site of injection, needs sterile equipment.

54
Q

Rectal Administration

A

Via rectum. Easy route and has the advantage of circumventing the intestinal tract.

55
Q

Intraperitoneal Administration (IP)

A

In gut. Most commonly used in animal experimentation (larger area).

56
Q

Gaseous/Inhalation Administration

A

Inhaled. Easy and speedy route with large absorption surface and no necessary injection equipment, though can be difficult to measure dosage and drug may irritate or damage nasal passages/lungs

57
Q

Distribution

A

Movement of drug from site of administration to the blood circulation to the body. Influenced by route of administration and liberation factors.

58
Q

Topical Administration

A

On skin. Localized action of effects and ease of self-administration. However, may be absorbed into general circulation.

59
Q

Transdermal Administration

A

Through skin. Produces controlled and prolonged absorption, but is useful only for lipid soluble drugs and may cause local irritation.

60
Q

Epidural Administration

A

Around epidural area at base of spinal cord. Very effective as it bypasses the blood-brain barrier with a rapid effect on the CNS, but is irreversible and requires a trained anesthesiologist to avoid possible nerve damage.

61
Q

Elimination

A

Duration of effectiveness before a drug is broken down and inactivated, measured by half-life and drug metabolism (biotransformation) in liver. Most drugs only meant to have a temporary action.

62
Q

Biotransformation

A

Drug metabolism wherein drug broken down in liver into metabolite. Two phases/types that inactive drugs and make them water soluble so they are easier to excrete.

63
Q

Phase 1 of Biotransformation

A

Phase 1: modification of parent structure by oxydiation or hydrolysis, producing a polar metabolite that can be excrete through urine.

64
Q

Phase 2 of Biotransformation

A

Phase 2: Conjugation with a salt/amino acid, producing an ionized, biologically inactive molecule.

65
Q

Tolerance

A

More drug is required to produce a desired effect. Due to DA receptor downregulation.

66
Q

Withdrawal

A

Physical and psychological symptoms opposite from those the drug induces. Upon removal of A-Process, body is left with a strengthened but unopposed B-Process -> strong opposite effects.

67
Q

Opponent-Process Theory of Addiction

A

The body strives to maintain homeostasis, thus when drug produces change from homeostasis (A-Process), body tries to reduce changes by producing opposite effects (B-Process).

68
Q

Addiction

A

Physiological and psychological need for drug. Increases the strength of a body’s B-Processes, requiring stronger or more frequent A-processes.

69
Q

Alcohol

A

Naturally occurring byproduct of distilling and fermenting sugar.
Administration: beverage.
Distribution: small intestine (rapid).
Elimination: liver metabolization.
Long-term effects: Korsakoff’s disease (memory loss due to thiamine deficiency), Liver Cirrhosis, Fetal Alcohol Syndrome in children of drinking mothers (low birth weight, IQ)

70
Q

Marijuana

A

Active ingredient: THC. Low doses: sedative/hypnotic. High doses: euphoria, hallucination.
Administration: Inhalation, ingestion
Distribution: Through lungs. Peak concentration in 30 mins, behavioral peak 2-3 hours.
Elimination: 30 hours half-life to leave bodyfat.
CNS effects: short term: mood alterations, increased appetite (disinhibition of hunger control), distortion of time. Long term: lung pathologies, immunosuppression.
Used for reduction of pain for glaucoma, nausea relief for chemotherapy/AIDs patients

71
Q

Membrane Theories of CNS Depressants

A

Alcohol: causes neuronal membrane to become more flexible, reduces efficiency of neuronal transmission, disrupts activity of membrane receptors.
Marijuana: THC affects membrane surrounding certain receptor site.

72
Q

Receptor Theories of CNS Depressants

A

Alcohol: Binds to and influences the activity of GABA receptor (results in inhibition by increasing Cl- influx), Glutamate receptor (inhibition by decreasing Ca++ influx). [Increase inhibition, decrease excitation]
Marijuana: Specific cannabinoid receptor concentrated in BG and CB (motor effects), and front cortex (euphoria, relaxation, temporal distortion). Also endogenous ligand for cannabinoid receptors (anandamide).

73
Q

Sedatives and Tranquilizers

A

Decrease anxiety by producing global depression of CNS. Super-addictive effects: combination of different types can lead to potentially lethal combinations.

74
Q

Barbituates

A

Class of synthetic compounds, usually taken orally, though differ in length of action. Currently used as sleep aids and anticonvulsants.
Low dose effects: euphoria, loss of behavioral inhibition by acting as a GABA allosteric agonist.
Risks: addiction, tolerance, insomnia on withdrawal

75
Q

Benzodiazapines

A

Synthetic compounds used as one of the most widely prescribed (anti-anxiety) drugs. Taken orally. GABA allosteric agonist. Used to treat anxiety disorders. Side effects: lethargy, drowsiness. Great hazard of overdose if combined with alcohol. Ex: Valium, Xanax, Librium. High addictive potential.

76
Q

GABA Channels and Sedatives

A

Benzos/Barbs are allosteric GABA agonists, thus activate Cl- influx (inhibition). Mixing with alcohol (also Cl- increasing and Ca++ reducing) leads to supra inhibition which may inhibit neural centers involved in respiration, heart rate, blood pressure, etc -> DEATH

77
Q

Nicotine

A

Stimulant (alertness, irritability, hunger suppression, increased blood pressure/heart rate). Primary active ingredient in tobacco products.
Administration: inhalation, chewing
Distribution: absorption through lungs
Elimination: metabolized into inactive compounds within 2 hours.
Risks: long-term toxicities due to tar/chemicals from burning -> cancers/heart disease.

78
Q

Caffeine

A

Most widely used drug in the world (stimulant).
Effects: adenosine (sedation, bronchospasm) receptor antagonist, increase in alertness, decrease in fatigue, ease in breathing
Administration: 80% of adults drink 3 cups of coffee (200-300 mg) a day.
Distribution: Rapid stomach/small intestine absorption. Significant blood levels within 30 minutes, peak after 2 hours.
Elimination: half-life of 3-5 hours
Risk: Nervousness, hyperventilation, possibility of panic attacks, insomnia, irritability

79
Q

Amphetamines

A

Synthetic compound with a chemical structure similar to catecholamines.
Administration: oral, nasal, IV
Distribution: blood stream
Elimination: half-life of 18-24 hours (liver metabolization)
Effects: increase in blood pressure, motor activity, libido, pain threshold, decrease in bronchial muscle tone, fatigue, appetite, euphoria. High doses lead to paranoia
Risks: fatal overdose due to cerebral hemorrhage.
Related to Ritalin

80
Q

Cocaine

A

Derived from coca plant.
Administration: nasal, smoked (crack)
Distribution: nasal (mucosal membrane). inhaled (absorbed directly into blood)
Elimination: half life of 15-30 minutes. Metabolized by specific esterase enzyme in brain.
Effects: increased heart rate, blood pressure, body temp, euphoria.
Risks: cardiovascular, cerebrovascular problems
Genetic variant of esterase can predispose users to death.

81
Q

Dopamine Re-Uptake Mechanism of Action

A

Catecholamines usually inactivated by reuptake at synapse. Cocaine/amphetamines block reuptake process amplifying DA effects. Amphs also increase DA release extending activity time.

82
Q

Peyote

A

Active ingredient: mescaline.
Taken orally in the form of dried cactus tops (buttons). Absorbed rapidly by gut, producing significant levels in the brain at 30-60 minutes, physiological effects can last for 10 hours.
Effects: small doses: increase blood pressure, heart rate, and pupil dilation. Larger doses: hallucinations.
Risks: Neuronal cell death as it is a potent neuronal excitotoxin.

83
Q

Ecstasy

A

Synthetic of mescaline (MDMA). Dangerous and potent toxin of serotonin cells.

84
Q

LSD

A

Best known hallucinogenic. Acts by inhibiting inhibitory (serotonin) neurons to produce excitation. Taken orally as blots/sugar cubes. onset 30-60 minutes, halflife of 3 hours, can last 10-12 hours.
Effects: increased heart rate, pupil dilation, perceptual alterations, occasional psychotic episodes and synesthesia. Not addictive, though tolerance may form.
Risk: psychotic break leading to suicide.

85
Q

Psilocybin

A

“Magic Mushrooms”. Oral ingestion, body converts mushroom to psilocin (200x less powerful than LSD). Produces distortions of thought, perception.

86
Q

Morphine

A

Opiate. Typically taking IV or orally. Eliminated by liver. CNS effects include analgesia, euphoria, sedation.
Risk: respiratory depression (stop breathing as respiratory systems are inhibited)

87
Q

Heroin

A

Synthetic derivative of morphine (10x more powerful. Very dangerous)

88
Q

Heterogeneity of Opiate Receptors

A
4 different receptors for endogenous opiates
Mu opiate receptor: pain analgesia
kappa: pain analgesia
delta: altering affect and euphoria
sigma: dysphoria, feelings of discomfort
89
Q

Natural Agonists and Synthetic Opiate Antagonists

A

Endogenous Opiates: enkephalins, beta-endorphins, dynorphins.
Pharmaceutical Antagonists: naloxene, naltrexone: bind receptors more tightly = emergency treatment as competitors for drug overdose victims

90
Q

Diagnostic and Statistical Manual

A

Attempts to draw contrast between disorders that are biological in nature and those that are psychological in nature.

91
Q

Senility

A

Previously thought to be single disease. Now known to be collection of specific disease states including Alzheimer’s and Multi-Infarct Dementia.

92
Q

Alzheimer’s Disease

A

Progressive mental deterioration with memory loss, confusion, and disorientation in mid- to late-life.

93
Q

Multi-Infarct Dementia

A

Step-like deterioration in intellectual function resulting from decreased blood flow to the hemispheres due to strokes.

94
Q

Division of Psychiatric Problems

A

Psychological complaints (treated by therapy) and brain disorders (treated by drugs)

95
Q

Schizophrenia

A

Group of disorders comprising 6-month period of disturbances in communication, perception, and thought. Not a mood disorder, but disorder of perception and comprehension of reality with sensory abnormality (false realities [hallucinations, synesthesia] that conflict with cognition)

96
Q

Symptoms of Schizophrenia

A

Florid Symptoms: disorganized thinking, paranoia, delusions of grandeur, bizarre ideation.
Negative Symptoms: neglect of personal hygiene, odd behavior and ideas, social isolation, withdrawal, catatonia. (Negative often precede Florid symptoms)

97
Q

Rule of Thirds of Schizophrenia

A

1/3 recover, 1/3 remiss and relapse, 1/3 chronically ill.

98
Q

Treatment of Schizophrenia

A

Neuroleptics (Atypical Antipsychotics like Thorazine) reduce florid symptoms, do not affect negative symptoms and leave sedative effect.
Hospitalization climbed through the 1900’s before dropping off with new drug therapies.

99
Q

Neuroleptic Drugs

A

Dopamine receptor antagonists, blocking D2. Suggests that underlying problem in schizophrenia is excess DA transmission in certain areas of the brain, notably the thalamus (DA Hypothesis)

100
Q

Genetic Factors and Schizophrenia

A

Twin studies show a correlation between shared genes and development of schizophrenia

101
Q

Brain Differences in Schizophrenia

A

PET scans show that schizophrenics have larger cerebral ventricles than normal

102
Q

Viral Causes and Schizophrenia

A

Dramatic increase in the birthrate of schizophrenics among women who developed flu in the 2nd trimester

103
Q

Affective Disorders

A

Person perceives reality normally, but feelings and affect about that reality are distorted. Include Mania, unipolar/bipolar illness

104
Q

Mania

A

Symptoms include accelerated thought process, euphoria, exaggerated sexual or physical appetite, illusions of invincibility, and grandiose ambitions. Treated by Lithium (Li+Cl-)

105
Q

Unipolar and Bipolar Illness

A

Mania often relapses, resulting in periods of depression. Symptoms of depression: Expressions of Helplessness, Hopelessness, and Worthelessness. Also, suicidal thoughts, anhedonia, psychomotor retardation, sleep disturbances resulting in lost REM sleep. Unipolar illness: depression w/o mania. Bipolar illness: brief periods of depression/mania interspersed with normalcy.

106
Q

Depression on a Diagnostic Continuum

A

Most experience transcient depression. Traumatic events lead to short-term depression (Reactive Depression). Drug therapy helps all along the continuum.

107
Q

Monoamine Hypothesis and Depression

A

Monoamine Hypothesis: abnormality in monaminergic transmission underlies almost all mental illnesses. Depression hypothesis: too little catecholamines (DA/NE). Thus, 1st drugs designed to increase extracellular catecholamines.

108
Q

MAO Inibitors

A

Block the breakdown of catecholamines, increasing their levels. Alleviates depression. Similar effect as amphetamines. Side effects: accelerated heart rate, hypertension

109
Q

Tricyclics

A

Block monoamine reuptake by binding to the pump, elevating extracellular monoamine levels. Structure resembles neuroleptics. Developed as a drug affecting only depression-related sites of the brain. Less cardiovascular effects than MAOIs.

110
Q

Atypical Antidepressants

A

Selective Serotonin Reuptake Inhibitors: selectively block serotonin reuptake thus raising extracellular levels of serotonin. Therapeutic effects take weeks, though biochemical effects are immediate. Increase 5HT in all parts of brain, leading to loss of some pleasure drives

111
Q

Anxiety Disorders

A

Symptoms include intense dread and generalized avoidance.

Treated by anxiolytics (benzo family) which act as tranquilizers

112
Q

Hazards of Medication

A

Poor understanding of modes of action -> unknown side effects. Addictive prescription drugs with withdrawal effects. Meds may exacerbate pre-existing conditions. Drugs in combination may be lethal. Developmental use produces unknown brain changes. Long-term maintenance leads to poorly understood brain changes.